Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2010 May;12(3):165-73.
doi: 10.1007/s11908-010-0099-y.

Drug-Resistant Malaria: The Era of ACT

Affiliations

Drug-Resistant Malaria: The Era of ACT

Jessica T Lin et al. Curr Infect Dis Rep. 2010 May.

Abstract

As drug-resistant falciparum malaria has continued to evolve and spread worldwide, artemisinin-based combination therapies (ACT) have become the centerpiece of global malaria control over the past decade. This review discusses how advances in antimalarial drug resistance monitoring and rational use of the array of ACTs now available can maximize the impact of this highly efficacious therapy, even as resistance to artemisinins is emerging in Southeast Asia.

PubMed Disclaimer

Conflict of interest statement

Disclosure: No potential conflict of interest relevant to this article was reported.

Figures

Fig. 1
Fig. 1
Number of countries adopting ACTs as first-line therapy by year, disaggregated by specific ACT drug. Each value marked indicates the cumulative number of countries having adopted the ACT by that year. The statistics shown are for policy adoption and do not necessarily represent policy implementation. AL artemether-lumefantrine; ASAQ artesunate-amodiaquine; AS-SP artesunate-sulfadoxine-pyrimethamine; ASMQ artesunate-mefloquine; DHA-PQ dihydroartemisinin-piperaquine. (Data from World Health Organization [–20])

References

    1. Trape JF. The public health impact of chloroquine resistance in Africa. Am J Trop Med Hyg. 2001;64:127. - PubMed
    1. World Health Organization. Methods for Surveillance of Antimalarial Drug Efficacy. Geneva: World Health Organization; 2009.
    1. Laufer MK. Monitoring antimalarial drug efficacy: current challenges. Curr Infect Dis Rep. 2009;11:59–65. - PMC - PubMed
    1. Price RN, Uhlemann AC, Brockman A, et al. Mefloquine resistance in Plasmodium falciparum and increased pfmdr1 gene copy number. Lancet. 2004;364:438–447. - PMC - PubMed
    1. Lim P, Alker AP, Khim N, et al. Pfmdr1 copy number and arteminisin derivatives combination therapy failure in falciparum malaria in Cambodia. Malar J. 2009;8:11. - PMC - PubMed